
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
Thrombolytic therapy for stroke with the introduction of tissue plasminogen activator (t-PA) was a boon to stroke physicians, since it meant that morbidity and mortality could be reduced with the optimal use of t-PA. The editor and his well-respected contributors offer the reader their personal perspectives on the evidence-based use of various thrombolytic and anti-thrombotic agents that are available and that can provide successful outcomes. Up-to-date and thoroughly referenced, this clearly written text is a resource everyone working in the casualty/emergency room will want at their fingertips.
This text investigates the clinical application and evidence-based efficacy of thrombolytic and antithrombotic agents in the management of acute stroke. Edited by Hacke and Bogousslavsky, the work compiles expert perspectives on the administration of tissue plasminogen activator (t-PA) and other pharmacological interventions. It provides a structured framework for physicians to optimize patient outcomes by balancing morbidity reduction with therapeutic safety protocols. The content relies on clinical data and peer-reviewed research to guide decision-making in high-pressure medical environments.
What You Will Find
Medical professionals frequently cite this text as a practical reference for emergency stroke management. Experts highlight the clinical utility of the contributors' perspectives in navigating the complexities of acute pharmacological intervention.
Page Count:
272
Publication Date:
2004-01-01
Publisher:
Taylor & Francis Group
ISBN-10:
0203502388
ISBN-13:
9780203502389
No comments yet. Be the first to share your thoughts!